These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
287 related items for PubMed ID: 11869627
1. Pressurised metered-dose inhalers versus all other hand-held inhalers devices to deliver bronchodilators for chronic obstructive pulmonary disease. Ram FS, Brocklebank DM, Muers M, Wright J, Jones PW. Cochrane Database Syst Rev; 2002; 2002(1):CD002170. PubMed ID: 11869627 [Abstract] [Full Text] [Related]
3. Pressurised metered dose inhalers versus all other hand-held inhaler devices to deliver beta-2 agonist bronchodilators for non-acute asthma. Ram FS, Brocklebank DM, White J, Wright JP, Jones PW. Cochrane Database Syst Rev; 2002; 2002(1):CD002158. PubMed ID: 11869625 [Abstract] [Full Text] [Related]
4. Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering beta (2 )agonists bronchodilators in asthma. Ram FS, Wright J, Brocklebank D, White JE. BMJ; 2001 Oct 20; 323(7318):901-5. PubMed ID: 11668134 [Abstract] [Full Text] [Related]
5. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD. Brashier B, Dhembare P, Jantikar A, Mahadik P, Gokhale P, Gogtay JA, Salvi SS. Respir Med; 2007 Dec 20; 101(12):2464-71. PubMed ID: 17719763 [Abstract] [Full Text] [Related]
6. Bronchodilators delivered by nebuliser versus pMDI with spacer or DPI for exacerbations of COPD. van Geffen WH, Douma WR, Slebos DJ, Kerstjens HA. Cochrane Database Syst Rev; 2016 Aug 29; 2016(8):CD011826. PubMed ID: 27569680 [Abstract] [Full Text] [Related]
9. Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering corticosteroids in asthma. Brocklebank D, Wright J, Cates C. BMJ; 2001 Oct 20; 323(7318):896-900. PubMed ID: 11668133 [Abstract] [Full Text] [Related]
11. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over. Shepherd J, Rogers G, Anderson R, Main C, Thompson-Coon J, Hartwell D, Liu Z, Loveman E, Green C, Pitt M, Stein K, Harris P, Frampton GK, Smith M, Takeda A, Price A, Welch K, Somerville M. Health Technol Assess; 2008 May 20; 12(19):iii-iv, 1-360. PubMed ID: 18485271 [Abstract] [Full Text] [Related]
12. [Chinese expert consensus on standardized inhaler device application in stable chronic airway diseases (2023)]. Inhalation Therapy and Respiratory Rehabilitation Group, Respiratory Equipment Committee of China Association of Medical Equipment. Zhonghua Jie He He Hu Xi Za Zhi; 2023 Nov 12; 46(11):1055-1067. PubMed ID: 37914418 [Abstract] [Full Text] [Related]
15. In vitro validation of a Respimat® adapter for delivery of inhaled bronchodilators during mechanical ventilation. Dellweg D, Wachtel H, Höhn E, Pieper MP, Barchfeld T, Köhler D, Glaab T. J Aerosol Med Pulm Drug Deliv; 2011 Dec 12; 24(6):285-92. PubMed ID: 21870959 [Abstract] [Full Text] [Related]
16. Inhaled short-acting beta2-agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease. McCrory DC, Brown CD. Cochrane Database Syst Rev; 2001 Dec 12; 2001(2):CD002984. PubMed ID: 11406052 [Abstract] [Full Text] [Related]
18. New developments in inhaler devices within pharmaceutical companies: A systematic review of the impact on clinical outcomes and patient preferences. Ninane V, Vandevoorde J, Cataldo D, Derom E, Liistro G, Munghen E, Peché R, Schlesser M, Verleden G, Vincken W. Respir Med; 2015 Nov 12; 109(11):1430-8. PubMed ID: 26439177 [Abstract] [Full Text] [Related]